Rejuvatek names dermatologist Stephen Eubanks as inkOUT medical director

Rejuvatek Medical has tapped board-certified dermatologist Dr. Stephen Eubanks to guide clinical development of its inkOUT non-laser tattoo and permanent makeup removal system. The company will also unveil a next-generation inkOUT device at the Be+Well Conference in Las Vegas on June 27, with live demos at Booth #413.

Why it matters: - Rejuvatek is betting that deeper clinical leadership will help it build trust in a crowded tattoo-removal market. - Dr. Stephen Eubanks brings 40-plus years in dermatology, which could strengthen protocol development, provider education and clinical validation for inkOUT®. - The appointment comes as Rejuvatek pushes a next-generation device it says is designed to improve speed, comfort and effectiveness for tattoo and permanent makeup removal.

What happened: - Rejuvatek Medical named Dr. Stephen (Steve) Eubanks, MD, as Medical Director of its inkOUT® portfolio. - Rejuvatek said Dr. Eubanks will provide strategic clinical guidance and leadership for the continued development and optimization of inkOUT® treatments. - The company will debut its latest inkOUT® device at the Be+Well Conference in Las Vegas on June 27. - Attendees can visit Booth #413 for live treatment demonstrations.

The details: - Dr. Eubanks is a board-certified dermatologist with a background in cosmetic and laser dermatology. - He has been a Fellow of the American Academy of Dermatology. - Dr. Eubanks founded his private practice in 1984. - Advanced Dermatology and Cosmetic Surgery acquired that practice in 2015. - Rejuvatek said Dr. Eubanks will help refine protocols, support medical validation and set a high standard of care for patients and providers. - The company said Dr. Eubanks will also collaborate with clinical and marketing teams on treatment protocol optimization, clinical studies, physician and provider education, and broader adoption of inkOUT® in medical and aesthetic practices. - inkOUT® uses patented TEPR™ (Trans-Epidermal Pigment Release) technology to expel tattoo and permanent makeup ink through the skin’s surface. - Rejuvatek describes inkOUT® as a non-laser alternative designed to deliver faster clearance across all ink colors and skin types, with fewer sessions and improved patient comfort. - Rejuvatek is based in Utah and focuses on non-laser tattoo and permanent makeup removal technologies.

Between the lines: - Rejuvatek is positioning inkOUT® as a safer, clinically supported alternative to laser removal. - The company’s emphasis on faster clearance, broader efficacy and comfort suggests it is trying to differentiate on patient experience as well as results. - Dr. Eubanks’ involvement may also help Rejuvatek market the device to physicians and aesthetic practices that want more medical validation before adoption.

What's next: - Rejuvatek is expected to use Dr. Eubanks’ guidance as it advances clinical development and validation of the next-generation device. - The company will showcase the new system at Be+Well and offer live demonstrations to attendees. - Rejuvatek plans to continue building inkOUT® as a preferred non-laser option in medical and aesthetic settings.

The bottom line: - Rejuvatek is pairing a high-profile dermatology appointment with a product unveiling as it tries to accelerate credibility and growth for inkOUT®.